A Brief Version of Biofeedback Therapy for Panic Disorder

Sponsor
National Taiwan University Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT02826096
Collaborator
National Taiwan University Hospital, Yun-Lin Branch (Other)
34
1
2
63.9
0.5

Study Details

Study Description

Brief Summary

The study is to examine the therapeutic effect of a brief version of biofeedback therapy (developed bu the research team) on panic disorder. It is a randomized controlled design. The severity of panic symptoms of two groups of panic patients (reveiving biofeedback therapy or not) were measured before and after the six week duration. Besides, the severity of anxiety, depressive, somatic symptoms, and physiological indexes were recorded.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Biofeedback therapy
N/A

Detailed Description

The purpose of this study is trying to find out whether our newly developed brief version of biofeedback is an effective treatment approach for panic disorder. At the same time, the investigators want to clarify the change of bio- and psycho- indices present through the process. Patient recently experienced panic attacks are recruited in this study. The diagnosis of "Panic Disorder" is made by psychiatrists according to The Diagnostic and Statistical Manual of Mental Disorders(DSM-5) criteria. Subjects are randomly assigned to medication group or biofeedback therapy. The biofeedback therapy is conducted by psychologists following the structure way. Every subject will be measured both the bio and psycho indices on week 0, 3, and 6 under 6-week observation. In the end of the study, the investigators hope to analyze and clarify the treatment effects of our design, and also to exam the meanings of these indices, in order to find out an effective treatment approach.

Study Design

Study Type:
Interventional
Actual Enrollment :
34 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
A Brief Version of Biofeedback Therapy for Panic Disorder
Actual Study Start Date :
Dec 21, 2015
Actual Primary Completion Date :
Apr 18, 2021
Actual Study Completion Date :
Apr 18, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: biofeedback group

biofeedback therapy

Behavioral: Biofeedback therapy
The brief version of biofeedback therapy is conducted by psychologists following the structure way. Biofeedback therapy is six session treatment once a week.

No Intervention: medication group

only medication treament

Outcome Measures

Primary Outcome Measures

  1. Changes from baseline Panic Disorder Severity Scale (PDSS) [week 0, week 3, week 6]

    PDSS is a scale rating the severity of panic disorder. It is a 5-point Likert scale with 7 items. The scores range from 0 (lowest level of panic disorder) to 28 (highest level of panic disorder).

Secondary Outcome Measures

  1. Scores of Patient Health Questionnaire-15 (PHQ-15) [week 0, week 3, week 6]

    PHQ-15 is a scale rating the severity of somatic distress. It is a 3-point Likert scale with 15 items. The scores range from 0 (lowest level of somatic distress) to 30 (highest level of somatic distress).

  2. Scores of Health Anxiety Questionnaire (HAQ) [week 0, week 3, week 6]

    HAQ is a scale rating the severity of health anxiety. It is a 4-point Likert scale with 21 items. The scores range from 0 (lowest level of health anxiety) to 63 (highest level of health anxiety).

  3. Penn State Worry Questionnaire (PSWQ) [week 0, week 3, week 6]

    PSWQ is a scale rating the severity of worry. It is 5-point Likert scale with 16 items. The scores range from 1 (lowest level of worry) to 80 (highest level of worry).

  4. Scores of WHOQOL-BREF [week 0, week 3, week 6]

    It is a self-report questionnaire measuring health-related quality of life. It is a 4-point Likert scale with 28 items, which belong to 5 domains (the overall, physical, psychological, social and environmental domains). The scores of each domain are usually normalized with 0-20 or 0-100.

  5. Sheehan Function Inventory [week 0, week 3, week 6]

    It is a scale rating the function in various dimensions of work, social life, leisure activities, family life and family responsibilities.

  6. Scores of Beck Depression Inventory-II (BDI-II) [week 0, week 3, week 6]

    BDI- II is a scale rating the severity of depression. It is a 4-point Likert scale with 21 items. The scores range from 0 (lowest level of depression) to 63 (highest level of depression).

  7. Scores of Beck Anxiety Inventory (BAI) [week 0, week 3, week 6]

    BAI is a scale rating the severity of anxiety. It is a 4-point Likert scale with 21 items. The scores range from 0 (lowest level of anxiety) to 63 (highest level of anxiety).

  8. Degree of Change in Physiological Parameters [week 0, week 6]

    ProComp5 Infiniti (SA7525) Biofeedback System would be used. Heart rate variability, skin conductance, body temperature and respiratory rate would be measured.

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No

inclusion criteria: The panic disorder cases of the National Taiwan University Hospital Yunlin Branch Psychiatric outpatient department (Huwei, Douliou) have more than one time of panic attack in nearly three months.

exclusion criteria:

  1. The age is younger than 20 or older than 70 years.

  2. With psychotic symptoms or cognitive dysfunction.

  3. A major physical illness (physical illness with fatal risks, such as cancer, myocardial infarction)

  4. Unable to read or understand the questionnaire

Contacts and Locations

Locations

Site City State Country Postal Code
1 National Taiwan University Hospital Douliu Yun-Lin Taiwan 640

Sponsors and Collaborators

  • National Taiwan University Hospital
  • National Taiwan University Hospital, Yun-Lin Branch

Investigators

  • Principal Investigator: Kuan-Fu Lin, MD, National Taiwan University Hospital, Yun-Lin Branch

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
National Taiwan University Hospital
ClinicalTrials.gov Identifier:
NCT02826096
Other Study ID Numbers:
  • 201511031RIND
First Posted:
Jul 7, 2016
Last Update Posted:
Apr 21, 2021
Last Verified:
Apr 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by National Taiwan University Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 21, 2021